Katharina Gellhaus
Publications by Year
Research Areas
Virus-based gene therapy research, CRISPR and Genetic Engineering, Immune Cell Function and Interaction, T-cell and B-cell Immunology, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients – A study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD)(2014)101 cited
- → Versatile and Efficient Genome Editing in Human Cells by Combining Zinc-Finger Nucleases With Adeno-Associated Viral Vectors(2011)63 cited
- → Targeted Chromosomal Gene Modification in Human Cells by Single-Stranded Oligodeoxynucleotides in the Presence of a DNA Double-Strand Break(2006)50 cited
- → Fate of Recombinant Adeno-Associated Viral Vector Genomes During DNA Double-Strand Break-Induced Gene Targeting in Human Cells(2009)39 cited
- → The Nontoxic Cell Cycle Modulator Indirubin Augments Transduction of Adeno-Associated Viral Vectors and Zinc-Finger Nuclease-Mediated Gene Targeting(2012)39 cited
- → Impaired NK cells and increased T regulatory cell numbers during cytotoxic maintenance therapy in AML(2014)32 cited
- → The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patterns(2013)21 cited
- → The Ratio of Regulatory (FOXP3 +) to Total (CD3 +) T Cells Determined by Epigenetic Cell Counting and Cardiovascular Disease Risk: A Prospective Case-cohort Study in Non-diabetics(2016)9 cited
- → Specifications of qPCR based epigenetic immune cell quantification(2023)2 cited
- → Effect of tumor-infiltrating T-lymphocytes on the aggressiveness of epithelial ovarian tumors.(2012)